Biodexa Pharmaceuticals (BDRX) said Monday the US Food and Drug Administration granted fast-track designation for eRapa as a potential treatment for familial adenomatous polyposis.
Shares surged 44% as intraday trading volume catapulted to over 20.5 million from a daily average of about 139,000.
DatChat (DATS) disclosed Monday the upcoming launch of its Myseum platform, a digital content management and storage solution for families, groups, and individuals.
Shares jumped 10%, with intraday trading volume rising to nearly 860,000 compared with a daily average of more than 8.72 million.
Axsome Therapeutics (AXSM) shares surged 22% after the firm said Monday it agreed to a settlement with Teva Pharmaceuticals (TEVA) to resolve "all" patent litigation related to Auvelity.
More than 3.4 million shares traded intraday compared with a daily average of about 800,000.
Price: 5.83, Change: +1.76, Percent Change: +43.24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.